Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
Chinese Patent Office
Cipla
Johnson and Johnson
US Department of Justice
Medtronic
McKinsey
Deloitte

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078913

« Back to Dashboard

NDA 078913 describes PROTRIPTYLINE HYDROCHLORIDE, which is a drug marketed by Epic Pharma Llc, Sigmapharm Labs Llc, and West-ward Pharms Int, and is included in three NDAs. It is available from four suppliers. Additional details are available on the PROTRIPTYLINE HYDROCHLORIDE profile page.

The generic ingredient in PROTRIPTYLINE HYDROCHLORIDE is protriptyline hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Summary for 078913
Tradename:PROTRIPTYLINE HYDROCHLORIDE
Applicant:West-ward Pharms Int
Ingredient:protriptyline hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Pharmacology for NDA: 078913
Medical Subject Heading (MeSH) Categories for 078913
Suppliers and Packaging for NDA: 078913
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 078913 ANDA West-Ward Pharmaceuticals Corp. 0054-0210 N 0054-0210-25
PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 078913 ANDA West-Ward Pharmaceuticals Corp. 0054-0211 N 0054-0211-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Sep 16, 2008TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Sep 16, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Moodys
Cantor Fitzgerald
Baxter
Cipla
Teva
Daiichi Sankyo
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.